Hao-Wei Wang, M.D., Ph.D.

Hao-Wei Wang, M.D., Ph.D.

  • Center for Cancer Research
  • National Cancer Institute
Laboratory of Pathology


Dr. Wang is a hematopathologist focused on refining the diagnosis of hematologic malignancies. He is developing new strategies in multiparametric flow cytometry for detection of minimal residual diseases, characterization of therapeutic targets, and immune monitoring after targeted immunotherapy. He also has expertise in virus-associated lymphoproliferative disorders, including Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman disease and primary effusion lymphoma. He is developing new tools to improve the diagnosis and stratification of these diseases.

Areas of Expertise

1) hematopathology 2) flow cytometry 3) lymphomas


Selected Recent Publications

Antigen Loss after Targeted Immunotherapy in Hematological Malignancies

Ting Zhou, Hao-Wei Wang
41(3): 341-357, 2021.
Full-Text Article
[ Journal Article ]

Molecular assessment of clonality in lymphoid neoplasms

Wang HW and Raffeld M
Seminars in Hematology. 56(1): 37-45, 2019.
Full-Text Article
[ Journal Article ]

Diagnosis of Hodgkin lymphoma in the modern era

Wang HW, Balakrishna JP, Pittaluga S, Jaffe ES.
British Journal of Haematology. 184(1): 45-59, 2019.
Full-Text Article
[ Journal Article ]

Multicentric Castleman Disease: Where are we now?

Wang HW, Pittaluga S, Jaffe ES.
Seminars in Diagnostic Pathology. 33(5): 294-306, 2016.
Full-Text Article
[ Journal Article ]


General Supervisor, Technologist
Technologist (contr.)
Robert Honec
Technologist (contr.)
Richard (Ryan) Sochacki
Linda S. Weaver